Ironwood Pharmaceuticals

NASDAQ

IRWD

$5.95 -0.11 -1.85%

I dag aktiekurs

USA

Sektor: Sundhedspleje Industri: Bioteknologi

Få adgang
til vurderingen af Finrange-aktier

Med denne takst vil du være i stand til at bruge tjenesten uden begrænsninger, al information vil være tilgængelig

Få 7 dage gratis

938.32M

1.55B

1.31

157.70M

-47.99 %

Indikator	Selskab	Industri
P/E (LTM) Viser, hvor mange år investorens investering i virksomheden vil betale sig med overskud over de sidste 12 måneder.	-0.89	28.32
P/BV (LTM) Viser forholdet mellem aktiens markedspris og den aktuelle bogførte værdi.	-2.71	4.48
EV/EBITDA (LTM) Repræsenterer forholdet mellem virksomhedens værdi og dets EBITDA før skat i de seneste 12 måneder.	-1.57	11.33
Net Debt/EBITDA (LTM) En virksomheds gældsgrad, som angiver, hvor længe virksomheden skal køre på cash flow inden for de seneste 12 måneder for at betale sin egen gæld.	-0.62	0.25
ROE (LTM) Viser effektiviteten af at bruge selskabets aktiekapital. Med andre ord viser ROE hvor stor en del af virksomhedens nettooverskud for den investerede kapital over de sidste 12 måneder.	318.32	10.75

8.78$ 14.27$

Min Maks

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Adresse:

100 Summer Street, Boston, MA, United States, 02110

Firmanavn:

Ironwood Pharmaceuticals

Udsteder ticker: IRWD

ISIN: US46333X1081

Land: USA

Udveksle: NASDAQ

betalingsmiddel: $

IPO datoer: 2010-02-03

Sektor: Sundhedspleje

Industri: Bioteknologi

websted:

https://www.ironwoodpharma.com

On which stock exchange are Ironwood Pharmaceuticals (IRWD) stocks traded?

Ironwood Pharmaceuticals (IRWD) stocks are traded on NASDAQ.

What is the ticker of Ironwood Pharmaceuticals stocks (IRWD)?

The stock ticker of Ironwood Pharmaceuticals’s stocks or in other words, the code is IRWD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Ironwood Pharmaceuticals (IRWD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Ironwood Pharmaceuticals (IRWD) belongs to the «Sundhedspleje» sector and the «Bioteknologi» industry.

In what currency are Ironwood Pharmaceuticals (IRWD) stocks traded?

Ironwood Pharmaceuticals (IRWD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Ironwood Pharmaceuticals (IRWD) stocks today?

The current price of Ironwood Pharmaceuticals stocks on 28.05.2024 is 5.95 dollars. per share.

What is the dynamics of Ironwood Pharmaceuticals (IRWD) stocks from the beginning of the year?

Ironwood Pharmaceuticals (IRWD) quotes have increased by -52.05% from the beginning of the year up to 5.95 dollars. per 1 stocks.

How much did Ironwood Pharmaceuticals (IRWD) stocks increase in may 2024?

This month Ironwood Pharmaceuticals (IRWD) quotes have increased by -27.62% to 5.95 dollars. per share.

How much are Ironwood Pharmaceuticals (IRWD) stocks worth?

Today, on October, 28.05.2024 Ironwood Pharmaceuticals’s (IRWD) stocks cost 5.95 dollars..

What is the market capitalization of Ironwood Pharmaceuticals (IRWD)?

Capitalization is the market value of Ironwood Pharmaceuticals (IRWD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 28.05.2024, the market capitalization of Ironwood Pharmaceuticals (IRWD) is estimated at about 938315000 dollars.

Ironwood Pharmaceuticals

Bedømmelse Finrange

Kommende arrangementer Ironwood Pharmaceuticals

Oversigt

Økonomi

Nøglemålinger

Udbytte

Brancheoversigt

Begivenheder

Aktiediagram Ironwood Pharmaceuticals

Aktieanalyse Ironwood Pharmaceuticals

Prisændring Ironwood Pharmaceuticals pr år

Sammenfattende analyse Ironwood Pharmaceuticals

Aktionærstruktur Ironwood Pharmaceuticals

Omsætning og nettoindtægt Ironwood Pharmaceuticals

Aktienyheder Ironwood Pharmaceuticals